Abstract
The prognostic value of preoperative serum concentrations of carcinoembryonic antigen (CEA), CA 242, tissue polypeptide antigen (TPA), specific tissue polypeptide antigen (TPS) and human chorionic gonadotrophin beta (hCG beta) in 251 patients with colorectal cancer (39 Dukes' A, 98 Dukes' B, 56 Dukes' C and 58 Dukes' D) was investigated. When using the cut-off levels recommended for diagnostic purposes, there was a significantly longer overall survival in patients with low tumour marker levels compared with patients with elevated serum levels for all the investigated markers. In Dukes' stage B, C and D CA 242 emerged as a significant predictor of survival, whereas TPA, TPS and hCG beta showed a value only in Dukes' D. Unfortunately, no marker provided prognostic information in Dukes' A. In multivariate analysis, entering the tumour markers as continuous variables, Dukes' stage was the strongest prognostic factor, followed by CA 242. TPS, hCG beta and localisation of the tumour were also independent prognostic factors, whereas age, gender, CEA and TPA were not.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alfthan H., Haglund C., Roberts P., Stenman U. H. Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. Cancer Res. 1992 Sep 1;52(17):4628–4633. [PubMed] [Google Scholar]
- Bogenschütz O., Brümmendorf T., Staab H. J., Anderer F. A., Kieninger G. Prognostic value of preoperative serum CEA level compared to clinical staging. IV. Histological grading and tumor type in colorectal and gastric cancer. J Surg Oncol. 1986 Jul;32(3):165–173. doi: 10.1002/jso.2930320310. [DOI] [PubMed] [Google Scholar]
- Brümmendorf T., Anderer F. A., Staab H. J., Hornung A., Stumpf E., Kieninger G. Prognostic value of preoperative serum CEA level compared to clinical staging: III. An approach to scoring of prognostic factors in colorectal cancer. J Surg Oncol. 1985 Apr;28(4):263–269. doi: 10.1002/jso.2930280405. [DOI] [PubMed] [Google Scholar]
- Carpelan-Holmström M., Haglund C., Kuusela P., Järvinen H., Roberts P. J. Preoperative serum levels of CEA and CA 242 in colorectal cancer. Br J Cancer. 1995 Apr;71(4):868–872. doi: 10.1038/bjc.1995.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Deans G. T., Parks T. G., Rowlands B. J., Spence R. A. Prognostic factors in colorectal cancer. Br J Surg. 1992 Jul;79(7):608–613. doi: 10.1002/bjs.1800790706. [DOI] [PubMed] [Google Scholar]
- Dhar P., Moore T., Zamcheck N., Kupchik H. Z. Carcinoembryonic antigen (CEA) in colonic cancer. Use in preoperative and postoperative diagnosis and prognosis. JAMA. 1972 Jul 3;221(1):31–35. [PubMed] [Google Scholar]
- Filella X., Molina R., Grau J. J., Piqué J. M., Garcia-Valdecasas J. C., Astudillo E., Biete A., Bordas J. M., Novell A., Campo E. Prognostic value of CA 19.9 levels in colorectal cancer. Ann Surg. 1992 Jul;216(1):55–59. doi: 10.1097/00000658-199207000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goslin R., Steele G., Jr, Macintyre J., Mayer R., Sugarbaker P., Cleghorn K., Wilson R., Zamcheck N. The use of preoperative plasma CEA levels for the Stratification of patients after curative resection of colorectal cancers. Ann Surg. 1980 Dec;192(6):747–751. doi: 10.1097/00000658-198012000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hall N. R., Finan P. J., Stephenson B. M., Purves D. A., Cooper E. H. The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer. Br J Cancer. 1994 Sep;70(3):549–553. doi: 10.1038/bjc.1994.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hohenberger P., Schlag P. M., Gerneth T., Herfarth C. Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Predictive value and implications for adjuvant treatment based on multivariate analysis. Ann Surg. 1994 Feb;219(2):135–143. doi: 10.1097/00000658-199402000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jass J. R., Atkin W. S., Cuzick J., Bussey H. J., Morson B. C., Northover J. M., Todd I. P. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology. 1986 May;10(5):437–459. doi: 10.1111/j.1365-2559.1986.tb02497.x. [DOI] [PubMed] [Google Scholar]
- Kuusela P., Haglund C., Roberts P. J. Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases. Br J Cancer. 1991 Apr;63(4):636–640. doi: 10.1038/bjc.1991.146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lindmark G., Bergström R., Påhlman L., Glimelius B. The association of preoperative serum tumour markers with Dukes' stage and survival in colorectal cancer. Br J Cancer. 1995 May;71(5):1090–1094. doi: 10.1038/bjc.1995.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moertel C. G., O'Fallon J. R., Go V. L., O'Connell M. J., Thynne G. S. The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer. Cancer. 1986 Aug 1;58(3):603–610. doi: 10.1002/1097-0142(19860801)58:3<603::aid-cncr2820580302>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
- Nilsson O., Johansson C., Glimelius B., Persson B., Nørgaard-Pedersen B., Andrén-Sandberg A., Lindholm L. Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9. Br J Cancer. 1992 Feb;65(2):215–221. doi: 10.1038/bjc.1992.44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Slentz K., Senagore A., Hibbert J., Mazier W. P., Talbott T. M. Can preoperative and postoperative CEA predict survival after colon cancer resection? Am Surg. 1994 Jul;60(7):528–532. [PubMed] [Google Scholar]
- Steele G., Jr, Ellenberg S., Ramming K., O'Connell M., Moertel C., Lessner H., Bruckner H., Horton J., Schein P., Zamcheck N. CEA monitoring among patients in multi-institutional adjuvant G.I. therapy protocols. Ann Surg. 1982 Aug;196(2):162–169. doi: 10.1097/00000658-198208000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ståhle E., Glimelius B., Bergström R., Påhlman L. Preoperative serum markers in carcinoma of the rectum and rectosigmoid. I. Prediction of tumour stage. Eur J Surg Oncol. 1988 Aug;14(4):277–286. [PubMed] [Google Scholar]
- Ståhle E., Glimelius B., Bergström R., Påhlman L. Preoperative serum markers in carcinoma of the rectum and rectosigmoid. II. Prediction of prognosis. Eur J Surg Oncol. 1988 Aug;14(4):287–296. [PubMed] [Google Scholar]
- Turnbull R. B., Jr, Kyle K., Watson F. R., Spratt J. Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann Surg. 1967 Sep;166(3):420–427. doi: 10.1097/00000658-196709000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wanebo H. J., Rao B., Pinsky C. M., Hoffman R. G., Stearns M., Schwartz M. K., Oettgen H. F. Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med. 1978 Aug 31;299(9):448–451. doi: 10.1056/NEJM197808312990904. [DOI] [PubMed] [Google Scholar]
- Wang J. Y., Tang R., Chiang J. M. Value of carcinoembryonic antigen in the management of colorectal cancer. Dis Colon Rectum. 1994 Mar;37(3):272–277. doi: 10.1007/BF02048166. [DOI] [PubMed] [Google Scholar]
- Wiggers T., Arends J. W., Volovics A. Regression analysis of prognostic factors in colorectal cancer after curative resections. Dis Colon Rectum. 1988 Jan;31(1):33–41. doi: 10.1007/BF02552567. [DOI] [PubMed] [Google Scholar]
- Wolmark N., Fisher B., Wieand H. S., Henry R. S., Lerner H., Legault-Poisson S., Deckers P. J., Dimitrov N., Gordon P. H., Jochimsen P. The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Results from NSABP (National Surgical Adjuvant Breast and Bowel Project) clinical trials. Ann Surg. 1984 Apr;199(4):375–382. doi: 10.1097/00000658-198404000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
